RETRACTION: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial (vol 29, pg 354, 2023) (Retraction of Vol 29, Pg 354, 2023)

被引：0
|
作者：
Abdallah, M. S.
Mosalam, E. M.
Hassan, A.
机构：
来源：
CNS NEUROSCIENCE & THERAPEUTICS | 2024年 / 30卷 / 03期
关键词：
D O I：
10.1111/cns.14668
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Retraction: Abdallah MS, Mosalam EM, Hassan A, et al. Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. CNS Neurosci. Ther. 2023;29:354-364 () The above article, published online on November 07, 2022 in Wiley Online Library () has been retracted by agreement between the journal's Editor-in-Chief, Xiaoming Hu, and John Wiley and Sons Ltd. Following publication, the Editor-in-Chief raised concerns about the integrity of the clinical trial. An investigation revealed significant issues regarding the reliability of the reported data. As a result, the Editor-in-Chief no longer has confidence in the validity of the results presented in this article.
引用
收藏
页数：1
相关论文
共 50 条
  • [1] RETRACTED: Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial (Retracted Article)
    Abdallah, Mahmoud S.
    Mosalam, Esraa M.
    Hassan, Ahmed
    Ramadan, Ahmed N.
    Omara-Reda, Hend
    Zidan, Abdel-Aziz A.
    Samman, Waad A.
    El-Berri, Eman, I
    CNS NEUROSCIENCE & THERAPEUTICS, 2023, 29 (01) : 354 - 364
  • [2] RETRACTION: Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial (Retraction of Vol 29, Pg 669, 2016)
    Jamilian, Mehri
    Samimi, Mansooreh
    Kolahdooz, Fariba
    Khalaji, Farzaneh
    Razavi, Maryamalsadat
    Asemi, Zatollah
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2024, 37 (01):
  • [3] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Shahin Akhondzadeh
    Raofeh Ghayyoumi
    Farzin Rezaei
    Bahman Salehi
    Amir-Hossein Modabbernia
    Azad Maroufi
    Gholam-Reza Esfandiari
    Mehrangiz Naderi
    Fariba Ghebleh
    Mina Tabrizi
    Shams-Ali Rezazadeh
    Psychopharmacology, 2011, 213 : 809 - 815
  • [4] Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial
    Akhondzadeh, Shahin
    Ghayyoumi, Raofeh
    Rezaei, Farzin
    Salehi, Bahman
    Modabbernia, Amir-Hossein
    Maroufi, Azad
    Esfandiari, Gholam-Reza
    Naderi, Mehrangiz
    Ghebleh, Fariba
    Tabrizi, Mina
    Rezazadeh, Shams-Ali
    PSYCHOPHARMACOLOGY, 2011, 213 (04) : 809 - 815
  • [5] RETRACTION: The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial (Retraction of Vol 56, Pg 901, 2017)
    Sheikh, Mahdi
    Hantoushzadeh, Sedigheh
    Shariat, Mamak
    Farahani, Zahra
    Ebrahiminasab, Ozra
    EUROPEAN JOURNAL OF NUTRITION, 2022, 61 (08) : 4239 - 4239
  • [6] Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study
    Rezaei, Farzin
    Mesgarpour, Bita
    Jeddian, Alireza
    Zeionoddini, Atefeh
    Mohammadinejad, Payam
    Salardini, Elaheh
    Shahriari, Mona
    Zeinoddini, Arefeh
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2017, 32 (04)
  • [7] Pentoxifylline as adjunctive therapy in cognitive deficits and symptoms of schizophrenia: A randomized double-blind placebo-controlled clinical trial
    Sinichi, Farideh
    Hosseini, Farhad Farid
    Fayyazi-Bordbar, Mohammadreza
    Sinichi, Mohaddeseh
    Jamali, Jamshid
    Mohammadpour, Amirhooshang
    JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (10) : 1003 - 1010
  • [8] Pentoxifylline adjunct to risperidone for negative symptoms of stable schizophrenia: a randomized, double-blind, placebo-controlled trial
    Shamabadi, Ahmad
    Rafiei-Tabatabaei, Elham-Sadat
    Kazemzadeh, Kimia
    Farahmand, Kimia
    Fallahpour, Bita
    Ardakani, Mohammad-Reza Khodaei
    Akhondzadeh, Shahin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 (01):
  • [9] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
  • [10] Escitalopram in the treatment of negative symptoms in chronic schizophrenia patients: A randomized double-blind placebo-controlled trial
    Iancu, I.
    Tchernihovsky, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 140 - 140
12345